What is Tristar Wellness?
engages in the development, marketing, and sale of wound care products.
TWSI · Verdict
Limited reward · moderate risk
TWSI's standout is balance sheet; volatility and profitability weigh on the picture.
Based on 75% data coverage
TWSI · Verdict
Top decile vs peers
Weak vs peers
0% return on equity
Earnings -88.7% CAGR
Model-based scoring. For information only — not financial advice.
engages in the development, marketing, and sale of wound care products. The company offers skincare and other products under the Beaute de Maman name for pregnant and nursing women; bleeding and wound management products for surgical, health care, consumer, and military markets; and develops and markets Delivery Devise with Invertible Diaphragm, which is a medical applicator for delivering medicants and internal devices within the body without producing injury or damage. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 6.07M.
The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.